Episode 60
Biotech Hangout
00:00
The Coherence of the Private Markets
Mike Yee: Don't expect that it's going to be rip-roin, but expect that slowly and steadily these products will come out. Torapalumab is a PD-1 that was developed by a Chinese developer called Junxi. And the hang-up is that they haven't been able to do a plant inspection because of the COVID situation in China. But I think this is something that other drug developers should be aware of and maybe watch closely.
Transcript
Play full episode
